Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.95 HKD
Change Today -0.05 / -1.67%
Volume 12.0K
8049 On Other Exchanges
Symbol
Exchange
Berlin
As of 4:01 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

jilin province huinan-h (8049) Snapshot

Open
$2.90
Previous Close
$3.00
Day High
$2.95
Day Low
$2.90
52 Week High
04/9/15 - $5.20
52 Week Low
08/24/15 - $2.55
Market Cap
1.7B
Average Volume 10 Days
128.6K
EPS TTM
$0.25
Shares Outstanding
172.5M
EX-Date
10/10/12
P/E TM
9.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for JILIN PROVINCE HUINAN-H (8049)

Related News

No related news articles were found.

jilin province huinan-h (8049) Related Businessweek News

No Related Businessweek News Found

jilin province huinan-h (8049) Details

Jilin Province Huinan Changlong Bio-pharmacy Company Limited, together with its subsidiaries, primarily manufactures and distributes biochemical medicines under the Changlong and Shendi brand names in the People’s Republic of China. Its principal products cover inter alia antibiotics and medicines for the treatment of cerebral embolism, brain and heart blood vessels related diseases, hepatitis, diabetes, prostatic diseases, pain and bleeding caused by cancer and surgery, hormone disorder, inflammation of gallbladder, gallstones, and traumatic injury. It is also involved in the trading of biochemical medicines. The company, formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited, was founded in 1989 and is based in Mongkok, Hong Kong.

450 Employees
Last Reported Date: 08/14/15
Founded in 1989

jilin province huinan-h (8049) Top Compensated Officers

Executive Chairman, General Manager, Complian...
Total Annual Compensation: CNY473.0K
Chief Finance Officer and Executive Director
Total Annual Compensation: CNY219.0K
Chief Engineer and Executive Director
Total Annual Compensation: CNY274.0K
Deputy General Manager, Executive Director an...
Total Annual Compensation: CNY253.0K
Compensation as of Fiscal Year 2014.

jilin province huinan-h (8049) Key Developments

Jilin Province Huinan Changlong Bio-Pharmacy Co. Ltd. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Jilin Province Huinan Changlong Bio-Pharmacy Co. Ltd. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported turnover of RMB 142,547,000 against RMB 134,574,000 a year ago. Profit from operations was RMB 46,777,000 against RMB 43,975,000 a year ago. Profit before taxation was RMB 46,697,000 against RMB 43,877,000 a year ago. Profit attributable to equity holders of the company was RMB 39,692,000 or 7.08 cents per share basic against RMB 37,295,000 or 6.66 cents per share basic a year ago. For the six months, the company reported turnover of RMB 264,277,000 against RMB 242,303,000 a year ago. Profit from operations was RMB 64,168,000 against RMB 58,493,000 a year ago. Profit before taxation was RMB 64,013,000 against RMB 58,280,000 a year ago. Profit attributable to equity holders of the company was RMB 54,411,000 or 9.71 cents per share basic against RMB 49,538,000 or 8.84 cents per share basic a year ago. Net cash inflow from operating activities was RMB 43,985,000 against RMB 39,256,000 a year ago.

Jilin Province Huinan Changlong Bio-Pharmacy Co. Ltd. to Report First Half, 2015 Results on Aug 13, 2015

Jilin Province Huinan Changlong Bio-Pharmacy Co. Ltd. announced that they will report first half, 2015 results on Aug 13, 2015

Jilin Province Huinan Changlong Bio-Pharmacy Co. Ltd., Board Meeting, Aug 13, 2015

Jilin Province Huinan Changlong Bio-Pharmacy Co. Ltd., Board Meeting, Aug 13, 2015., at 10:00 China Standard Time. Agenda: To approve the unaudited interim results of the company and its subsidiaries for the six months ended 30 June 2015 and to approve the draft announcement of the unaudited interim results of the Group for the six months ended 30 June 2015 to be published on the GEM website; to consider the payment of an interim dividend, if any; to consider the closure of the Register of Members, if necessary; and to consider the other matters, if any.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8049:HK $2.95 HKD -0.05

8049 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8049.
View Industry Companies
 

Industry Analysis

8049

Industry Average

Valuation 8049 Industry Range
Price/Earnings 9.6x
Price/Sales 2.1x
Price/Book 2.0x
Price/Cash Flow 9.6x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JILIN PROVINCE HUINAN-H, please visit www.jlchanglong.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.